AI Article Synopsis

  • Recent findings highlight that mutations in the LIPT1 gene, crucial for attaching lipoic acid to specific enzyme complexes, may lead to metabolic disorders like Leigh disease.
  • A young patient exhibited deficiencies in key enzymes (PDH and α-KGDH) and showed abnormal amino acid profiles, prompting exome sequencing and functional studies on his fibroblasts.
  • The study revealed mutations in LIPT1, leading to low enzyme activity and mitochondrial dysfunction, but lipoic acid treatment improved cell functions, suggesting potential therapeutic strategies.

Article Abstract

Background: Synthesis and apoenzyme attachment of lipoic acid have emerged as a new complex metabolic pathway. Mutations in several genes involved in the lipoic acid de novo pathway have recently been described (i.e., LIAS, NFU1, BOLA3, IBA57), but no mutation was found so far in genes involved in the specific process of attachment of lipoic acid to apoenzymes pyruvate dehydrogenase (PDHc), α-ketoglutarate dehydrogenase (α-KGDHc) and branched chain α-keto acid dehydrogenase (BCKDHc) complexes.

Methods: Exome capture was performed in a boy who developed Leigh disease following a gastroenteritis and had combined PDH and α-KGDH deficiency with a unique amino acid profile that partly ressembled E3 subunit (dihydrolipoamide dehydrogenase / DLD) deficiency. Functional studies on patient fibroblasts were performed. Lipoic acid administration was tested on the LIPT1 ortholog lip3 deletion strain yeast and on patient fibroblasts.

Results: Exome sequencing identified two heterozygous mutations (c.875C > G and c.535A > G) in the LIPT1 gene that encodes a mitochondrial lipoyltransferase which is thought to catalyze the attachment of lipoic acid on PDHc, α-KGDHc, and BCKDHc. Anti-lipoic acid antibodies revealed absent expression of PDH E2, BCKDH E2 and α-KGDH E2 subunits. Accordingly, the production of 14CO2 by patient fibroblasts after incubation with 14Cglucose, 14Cbutyrate or 14C3OHbutyrate was very low compared to controls. cDNA transfection experiments on patient fibroblasts rescued PDH and α-KGDH activities and normalized the levels of pyruvate and 3OHbutyrate in cell supernatants. The yeast lip3 deletion strain showed improved growth on ethanol medium after lipoic acid supplementation and incubation of the patient fibroblasts with lipoic acid decreased lactate level in cell supernatants.

Conclusion: We report here a putative case of impaired free or H protein-derived lipoic acid attachment due to LIPT1 mutations as a cause of PDH and α-KGDH deficiencies. Our study calls for renewed efforts to understand the mechanisms of pathology of lipoic acid-related defects and their heterogeneous biochemical expression, in order to devise efficient diagnostic procedures and possible therapies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905285PMC
http://dx.doi.org/10.1186/1750-1172-8-192DOI Listing

Publication Analysis

Top Keywords

lipoic acid
32
patient fibroblasts
16
attachment lipoic
12
pdh α-kgdh
12
acid
11
lipoic
9
leigh disease
8
genes involved
8
lip3 deletion
8
deletion strain
8

Similar Publications

Article Synopsis
  • The study explores the unclear mechanisms behind abdominal aortic aneurysm (AAA) by analyzing gut microbiota in fecal samples from patients with AAA and healthy controls.
  • It was found that patients with AAA had higher levels of certain oral bacteria and lower levels of bacterial genes associated with alpha lipoic acid (ALA) biosynthesis in their feces.
  • These findings suggest potential for developing gut microbiome-based treatments for AAA, highlighting the role of gut bacteria in the condition's pathophysiology.
View Article and Find Full Text PDF

Background: The treatment of metabolic dysfunction-associated steatotic liver disease (MASLD) has focused on the control of comorbidities. (SM) and alpha-lipoic acid (ALA) have shown antioxidant and adjuvant effects on the control of metabolic disorders.

Aim: To evaluate whether the SM-ALA formulation (LUDLEV), in combination with the Mediterranean diet (MD), could improve MASLD-related liver injury.

View Article and Find Full Text PDF

Effects of Photobiomodulation on Burning Mouth Syndrome: A Systematic Review and Meta-Analysis.

J Oral Rehabil

January 2025

Universidade Federal de São Paulo-Escola Paulista de Medicina-UNIFESP-EPM, São Paulo, Brazil.

Objective: The objective of this research is to evaluate the effectiveness and safety of photobiomodulation or low-level laser therapy on burning mouth syndrome compared to placebo, no-laser, clonazepam and alpha-lipoic acid.

Methods: A systematic review of randomised clinical trials was performed. The databases consulted were MEDLINE, CENTRAL, LILACS, EMBASE and clinical trial registries ClincalTrial.

View Article and Find Full Text PDF

This study was aim to investigate the effects of lipoic acid (ALA) on performance, meat quality, serum biochemistry and antioxidant function of broilers under heat stress (HS). Two hundred1-day-old Cobb broilers were randomly divided into four treatment groups and each treatment consisted of 4 replicates of 10 broilers each. The treatment group adopts a 2 × 2 two-factor setting, which is divided into two diets (basic diet or 250 mg/kg ALA diet) and two temperatures (24 ± 1℃ or 33 ± 1℃).

View Article and Find Full Text PDF

Objectives: Diabetes mellitus is a chronic disease that has become more prevalent worldwide because of lifestyle changes. It leads to serious complications, including increased atherosclerosis, protein glycosylation, endothelial dysfunction, and vascular denervation. These complications impair neovascularization and wound healing, resulting in delayed recovery from injuries and an elevated risk of infections.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!